IMC Bringing Israeli Expertise
Into a Global Market

A Pharma Grade Medical Cannabis Brand Capturing
The Full Value Chain at Higher Margins

Play Video

Financial Overview

$1,644.89 Feb 12, 2019
Valuation at IPO $52.7B
IPO Share Price CAD$4
Founded Date2010
FoundersOren Shuster & Rafael Gabay
Last Funding TypePrivate
Number of Employees50

Funding Round

2 Funding Round

C$ 29.5M Total Funding Amount

Funding Rounds
2019 Private PlacementsC$ 20,400,000
2018 Private PlacementsC$ 9,131,000

Investments

Investments

Total Invesments Amount

Invesetments

Upcoming Events

IACM

Berlin, Germany I October 31 till November 2, 2019

CPhI

Frankfurt, Germany I November 5-7, 2019

Expopharm

Düsseldorf, Germany I September 25-28, 2019

View All Events

CSE Reports

q22019Quarterly Financial Statements Q2/2019
q12019Quarterly Financial Statements Q1/2019
annual-2018Annual Financial Statements 2018
See All Reports

Corporate Presentations

Corporate PresentationsNovember 2019
See All Presentions

News and Updates

April 29, 2019

Israel New Cannabis Reform has Begun

March 29, 2019

IMC will Sponsor Cannatech

February 5, 2019

GAP Certification

View All News

Technology and Innovation

Our Technology Innovation

IMC is one of the world & the most advanced cannabis cultivators. Utilizing a decade of cannabis growing.....

Read More